4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000133
Chief Financial Officer sold 2,179 shares at $24.79 ($54,017)
- Chief Financial Officer acquired 7,472 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,472 | 11,754 | D | ||
| 2023-09-28 | Sale : show line 2 in the form 10b5-1 | −2,179 | $24.79 | $54,017 | 9,575 | D |
| Open-market sales · 2,179 sh · avg $24.79 · $54,017 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-26 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −7,472 | 14,945 | D |
Loading xslF345X05/wk-form4_1695931360.xml…